Ohya, Kazuki
Kawaoka, Tomokazu
Namba, Maiko
Uchikawa, Shinsuke
Kodama, Kenichiro
Morio, Kei
Nakahara, Takashi
Murakami, Eisuke
Hiramatsu, Akira
Tsuge, Masataka
Yamauchi, Masami https://orcid.org/0000-0003-3573-5720
Imamura, Michio
Chayama, Kazuaki
Aikata, Hiroshi
Article History
Received: 25 February 2019
Accepted: 24 July 2019
First Online: 20 August 2019
Competing Interests
: Kazuaki Chayama has received honoraria from Bristol-Myers Squibb, MSD K.K., AbbVie Inc., Gilead Sciences, Dainippon Sumitomo Pharma and Mitsubishi Tanabe and research funding from Dainippon Sumitomo Pharma, MSD K.K., AbbVie Inc, Eisai, Toray, Otsuka, Chugai, Takeda, Roche, Mitsubishi Tanabe and Bristol-Byers Squibb. Michio Imamura has received research funding from Bristol-Myers Squibb. Other authors declare no competing interests.